Tri­al soft­ware group rais­es $45M to push de­cen­tral­ized stud­ies; $120M SPAC makes its way to Nas­daq

Af­ter watch­ing the en­tire clin­i­cal tri­al process go through a ma­jor makeover dur­ing the pan­dem­ic, an­oth­er soft­ware out­fit is mak­ing a play to help de­vel­op­ers get on the cut­ting edge of tri­al de­sign and de­cen­tral­ized ex­e­cu­tion.

Hobo­ken, NJ-based Cas­tor has just raised $45 mil­lion to fund de­vel­op­ment of soft­ware in­tend­ed to scale up their “di­rect-to-pa­tients” ap­proach glob­al­ly. This new round brings their to­tal fund­ing to $65 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.